LBA-5: A hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery: The TRACTION trial ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- When hospitals were randomly assigned...

LBA-3: Pirtobrutinib vs Bendamustine Plus Rituximab (BR) in Patients with CLL/SLL: First Results from a Randomized Phase III Study Examining a Non-Covalent BTK Inhibitor in Untreated Patients...

LBA-6: Phase 3 randomized study of teclistamab plus daratumumab versus investigator's choice of daratumumab and dexamethasone with either pomalidomide or bortezomib (DPd/DVd) in patients (Pts)...

Speakers and Exhibitors include Meta, Snap, AMD, HTC, Lenovo, Niantic Spatial, PICO, Siemens, Volkswagen, Novartis, Deutsche Telekom, Bosch, BBC, Airbus and more BRUSSELS, Dec. 9, 2025...

Today M&A Source® announces the results of the Fall 2025 Conference and Deal Market, held on November 11-12 in Phoenix, AZ. The event is an opportunity for lower middle market advisors and...